American Century Companies
ELDN icon

American Century Companies’s Eledon Pharmaceuticals ELDN Stock Holding History

American Century Companies’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,572
Closed -$55.9K – 2834
2025
Q3 		$55.9K Sell
21,572
-14,020
-39% -$41K ﹤0.01% 2767
2025
Q2 		$96.5K Buy
+35,592
New +$107K ﹤0.01% 2795

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

American Century Companies's ELDN Position: Q4 2025 in Review

American Century Companies sold out of Eledon Pharmaceuticals (ELDN) in Q4 2025, closing a stake of 21,572 shares — an estimated $55.9K sold.

American Century Companies first reported a position in ELDN in Q2 2025 and held it in 2 quarters. The position peaked at $96.5K in Q2 2025. 95 funds tracked by Wall St. Rank hold ELDN as of Q4 2025.

  • American Century Companies reported no remaining Eledon Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • American Century Companies sold 21,572 Eledon Pharmaceuticals shares in Q4 2025, an estimated $55.9K.
  • American Century Companies first reported a position in Eledon Pharmaceuticals in Q2 2025 and held it in 2 quarters.
  • American Century Companies's Eledon Pharmaceuticals position peaked at $96.5K in Q2 2025.
  • 95 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2025.

Based on American Century Companies's 13F filing for Q4 2025, filed 13 Feb 2026.